Santhera and Takeda Establish Collaboration to Develop and Market Idebenone (SNT-MC17) in Neuromuscular Disease

August 03, 2005 02:00 ET | Source: Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG